Your weekly roundup of the latest news from Drug Topics®.
As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.
Compared to the original mRNA-1273 booster dose, the bivalent booster mRNA -1273.222 was superior against Omicron variants.
Timing of treatment initiation is crucial for patients with cancer.
Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.
Confidence in vaccines is lower post-pandemic across all demographic groups.